Bio-Rad Laboratories (BIO) Long-Term Investments (2012 - 2026)

Bio-Rad Laboratories (BIO) has reported Long-Term Investments for 15 consecutive years, with $5.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Long-Term Investments rose 2.64% year-over-year to $5.7 billion in Q2 2026; TTM through Jun 2026 was $5.7 billion, a 2.64% increase from a year earlier, with the FY2025 full-year figure at $6.1 billion, up 26.13% from the prior year.
• Long-Term Investments was $5.7 billion for Q2 2026 at Bio-Rad Laboratories, up from $5.3 billion in the prior quarter.
• Over five years, Long-Term Investments peaked at $9.7 billion in Q1 2022 and troughed at $4.8 billion in Q4 2024.
• A 5-year average of $6.8 billion and a median of $6.7 billion in 2023 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments sank 54.04% in 2022 and gained 26.13% in 2025, its largest moves.
• Over 5 years, Long-Term Investments stood at $8.8 billion in 2022, then dropped by 12.83% to $7.7 billion in 2023, then plunged by 37.14% to $4.8 billion in 2024, then gained by 26.13% to $6.1 billion in 2025, then fell by 6.23% to $5.7 billion in 2026.
• The last three Long-Term Investments figures came in at $5.7 billion (Q2 2026), $5.3 billion (Q1 2026), and $6.1 billion (Q4 2025), per Business Quant data.